RS165722 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Urine X-12713 levels in chronic kidney disease | T | OR: 0.15 | 8E-39 | PubMed |
| X-11593 levels | — | OR: 0.43 | 3E-34 | PubMed |
| Glucuronide of piperine metabolite c17h21no3 (4) (X-01911) levels | C | OR: 0.18 | 2E-29 | PubMed |
| Urine glucuronide of piperine metabolite C17H21NO3 (3)* levels in chronic kidney disease | T | OR: 0.24 | 4E-20 | PubMed |
| Metabolite peak levels (QI4123) | T | OR: 0.26 | 4E-20 | PubMed |
| Plasma glucuronide of piperine metabolite C17H21NO3 (5)* levels in chronic kidney disease | T | OR: 0.22 | 2E-18 | PubMed |
| Urine 3,4-dihydroxyphenylacetate levels in chronic kidney disease | T | OR: 0.13 | 3E-17 | PubMed |
| Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | C | β: 0.025 | 4E-17 | PubMed |
| Plasma glucuronide of piperine metabolite C17H21NO3 (3)* levels in chronic kidney disease | T | OR: 0.2 | 1E-16 | PubMed |
| Metabolite peak levels (QI4144) | T | OR: 0.24 | 6E-16 | PubMed |
| Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | C | β: 0.023 | 2E-15 | PubMed |
| X-11593 levels | — | OR: 0.61 | 2E-15 | PubMed |
| Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | C | β: 0.023 | 3E-15 | PubMed |
| X-11849 levels | T | OR: 0.12 | 1E-14 | PubMed |
| Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | C | β: 0.021 | 1E-11 | PubMed |
| Apolipoprotein B levels | T | β: 0.014 | 2E-9 | PubMed |
| Low density lipoprotein cholesterol levels | C | β: 0.012 | 3E-9 | PubMed |
| Low density lipoprotein cholesterol levels | — | — | 5E-9 | PubMed |
| Body mass index | — | — | 5E-9 | PubMed |
| Body mass index | — | — | 8E-9 | PubMed |